ATE327736T1 - Liposomenhaltiges mittel zur behandlung gefässerkrankungen - Google Patents

Liposomenhaltiges mittel zur behandlung gefässerkrankungen

Info

Publication number
ATE327736T1
ATE327736T1 AT03021633T AT03021633T ATE327736T1 AT E327736 T1 ATE327736 T1 AT E327736T1 AT 03021633 T AT03021633 T AT 03021633T AT 03021633 T AT03021633 T AT 03021633T AT E327736 T1 ATE327736 T1 AT E327736T1
Authority
AT
Austria
Prior art keywords
liposome
treatment
vascular diseases
containing agent
biological data
Prior art date
Application number
AT03021633T
Other languages
English (en)
Inventor
Kazuhiro Aikawa
Original Assignee
Fuji Photo Film Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuji Photo Film Co Ltd filed Critical Fuji Photo Film Co Ltd
Application granted granted Critical
Publication of ATE327736T1 publication Critical patent/ATE327736T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dispersion Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT03021633T 2002-09-25 2003-09-25 Liposomenhaltiges mittel zur behandlung gefässerkrankungen ATE327736T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002278287A JP2004115397A (ja) 2002-09-25 2002-09-25 血管疾患治療薬を含むリポソーム

Publications (1)

Publication Number Publication Date
ATE327736T1 true ATE327736T1 (de) 2006-06-15

Family

ID=31973261

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03021633T ATE327736T1 (de) 2002-09-25 2003-09-25 Liposomenhaltiges mittel zur behandlung gefässerkrankungen

Country Status (5)

Country Link
US (1) US20040120999A1 (de)
EP (1) EP1402884B1 (de)
JP (1) JP2004115397A (de)
AT (1) ATE327736T1 (de)
DE (1) DE60305592T2 (de)

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BG40180A1 (en) * 1984-07-02 1986-11-14 Gbev Antihelminthic means and method for preparing the means
US6077529A (en) * 1988-05-06 2000-06-20 Schmidt; Karl Heinz Active ingredient system and method of manufacture thereof for transfer of lipophilic and amphiphilic components to target structures
US5043165A (en) * 1988-12-14 1991-08-27 Liposome Technology, Inc. Novel liposome composition for sustained release of steroidal drugs
US5088499A (en) * 1989-12-22 1992-02-18 Unger Evan C Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
US5387600A (en) * 1992-07-30 1995-02-07 Fuji Photo Film Co., Ltd. Treating arteriosclerosis using benzimidazole compositions
US5869462A (en) * 1992-09-10 1999-02-09 The Board Of Trustees Of The Leland Stanford Junior University Inhibition of proliferation of vascular smooth muscle cell
DE4330959A1 (de) * 1993-09-09 1995-03-16 Schering Ag Neue Benzimidazolderivate, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
AU1467595A (en) * 1994-02-04 1995-08-21 Fuji Photo Film Co., Ltd. 2-mercaptobenzimidazole derivative and antihyperlipemic or antiarteriosclerotic agent containing the same
US6139871A (en) * 1995-07-26 2000-10-31 The University Of British Columbia Liposome compositions and methods for the treatment of atherosclerosis
US5660855A (en) * 1995-02-10 1997-08-26 California Institute Of Technology Lipid constructs for targeting to vascular smooth muscle tissue
AU6369696A (en) * 1995-07-17 1997-02-18 Fuji Photo Film Co., Ltd. Benzimidazole compounds
WO1997035561A1 (en) * 1996-03-28 1997-10-02 The Board Of Trustees Of The University Of Illinois Materials and methods for making improved liposome compositions
PE11499A1 (es) * 1997-05-16 1999-03-01 Procter & Gamble Tratamiento del hiv y cancer
DE69825137T2 (de) * 1998-02-23 2005-07-21 Cilag Ag International Liposomale Erythropoietin-Dispersion
CA2407654C (en) * 2000-04-28 2009-06-30 Fuji Photo Film Co., Ltd. Liposome containing hydrophobic iodine compound
MXPA03002601A (es) * 2000-09-26 2005-02-25 Univ Arizona Foundation Compuestos y metodos de uso de los mismos en el tratamiento del cancer o de infecciones virales.
JP2004523565A (ja) * 2001-03-05 2004-08-05 トランス　テック　ファーマ，インコーポレイテッド 治療因子としてのベンゾイミダゾール誘導体
ATE375173T1 (de) * 2001-08-20 2007-10-15 Fujifilm Corp Hydrophobe iodverbindung enthaltendes liposom und dieses enthaltendes röntgenkontrastmittel

Also Published As

Publication number Publication date
JP2004115397A (ja) 2004-04-15
US20040120999A1 (en) 2004-06-24
EP1402884A1 (de) 2004-03-31
DE60305592T2 (de) 2007-04-26
EP1402884B1 (de) 2006-05-31
DE60305592D1 (de) 2006-07-06

Similar Documents

Publication Publication Date Title
DE60043587D1 (de) Mittel für erkrankungen assoziert mit knochensubstanzverlust
WO2004056307A3 (en) Disease treatment via antimicrobial peptide inhibitors
DE60320007D1 (de) Phenethanolamin-derivate zur behandlung von atemwegserkrankungen
DE69940131D1 (de) Mittel zur Behandlung von Erkrankungen der Speiseröhre
PT1263504E (pt) Compostos com actividade 5-ht1a uteis para o tratamento de perturbacoes da retina externa
DE60137635D1 (de) Verwendung von allopurinol zur behandlung von bluthochdruck
ATE132757T1 (de) Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit
DE50010284D1 (de) Arzneimittel zur behandlung von bluthochdruck
DE60027209D1 (de) Arzneimittel enthaltend hydroxyapatite zur behandlung von knochengewebserkrankungen
AU7966100A (en) Herbicidally active pyridine sulfonyl urea derivatives
TW200505408A (en) Agent for preventing and/or treating tissue disruption-accompanied diseases
ATE357912T1 (de) Intrakorporelle medikamente zur hoch- energetischen phototherapeutischen behandlung von krankheiten
ATE337005T1 (de) Nagellack enthaltend tazaroten und verwendung dessen zur behandlung und/oder zur prävention von psoriasis
DE50111407D1 (de) Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen
ATE330596T1 (de) Verwendung von 3-bezoylphenylessigsäure-derivaten zur behandlung von netzhauterkrankungen
WO2004056768A3 (en) Use of substituted 2,5-diamidoindoles for the treatment of urological diseases
ATE252383T1 (de) Verwendung von 2-methyl-thiazolidin-2,4- dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
NO20021410D0 (no) Forebygging og behandling av blodkoagulasjons-relaterte sykdommer
ATE327736T1 (de) Liposomenhaltiges mittel zur behandlung gefässerkrankungen
NO20032411L (no) Anvendelse av substituerte 6-dimetylaminometyl-1-fenyl- cykloheksan-forbindelser for behandling av urininkontinens
DE602004029993D1 (de) Pharmazeutische zusammensetzung zur behandlung von drogenabhängigkeit
EP1591130A3 (de) Verwendung einer aktiven Lösung zum Desinfizieren und/oder Sterilisieren einer zahnärztlichen Einheit
FR2854800B1 (fr) Procede d'obtention d'un principe actif pour des traitements de la peau seche, actions generees et actif obtenu
ATE474567T1 (de) Kombinationspräparate enthaltend 2- methylthiazolidin-2,4-dicarbonsäure
ATE270110T1 (de) Arzneimittel enthaltend tissue inhibitor of metalloproteinases-2 (timp-2) als osteoanabol wirksame substanz

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties